>> 全站文章索引 >> 第37页:
  • Impact of pain on depression treatment response in primary care - [Regenstrief Institute and the Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. mbair@regenstrief.org]
  • The Clinical Significance of Subsyndromal Depression in Older Primary Care Patients - [Lyness JM, Kim J, Tang W, Tu X, Conwell Y, King DA, Caine ED.]
  • Depression-Executive Dysfunction Syndrome in Stroke Patients - [Vataja, Risto M.; Pohjasvaara, Tarja M.; Mantyla, Riitta M.; Ylikoski, Raija Ph; Leskela, Maarit M.; Kalska, Hely Ph; Hietanen, Marja Ph; Juhani, Aronen Hannu; Salonen, Oili M.; Kaste, Markku M.; Leppavuori, Antero M.; Erkinjuntti, Timo M.]
  • Olanzapine Versus Haloperidol Treatmentin First-Episode Psychosis - [Todd M. Sanger, Ph.D., Jeffery A. Lieberman, M.D., Mauricio Tohen, M.D., Dr.P.H., Starr Grundy, B.Sc.Pharm., Charles Beasley, Jr., M.D., andGary D. Tollefson, M.D., Ph.D.]
  • Treatment of Giant Cell Arteritis Using Induction Therapy - [Mazlumzadeh M, Hunder GG, Easley KA, Calamia KT, Matteson EL, Griffing WL, Younge BR, Weyand CM, Goronzy JJ.]
  • Are gender differences important for the clinical effects of antidepressants - [Hildebrandt MG, Steyerberg EW, Stage KB, Passchier J, Kragh-Soerensen P; Danish University Antidepressant Group.]
  • phobic anxiety and depression increase the risk of ventricular arrhythmias in people with coronary artery disease - [Watkins LL, Blumenthal JA, Davidson JR, Babyak MA, McCants CB, Sketch MH.]
  • Variability in the Efficacy of Interferon- in Erdheim-Chester Disease by Patient and Site of Involvement - [Haroche J, Amoura Z, Trad SG, Wechsler B, Cluzel P, Grenier PA, Piette JC]
  • Phase II trial of docetaxel and carboplatin in recurrent platinum-sensitive ovarian, peritoneal and tubal cancer - [Strauss HG, Henze A, Teichmann A, Karbe I, Baumgart A, Thomssen C, Koelbl H.]
  • Profile of DSM-IV Major and Minor Depressive Disorders in First-Ever Stroke Patients - [Spalletta G, Ripa A, Caltagirone C.]
  • Symptom Profile of DSM-IV Major and Minor Depressive Disorders in First-Ever Stroke Patients - [Spalletta, Gianfranco M.; Ripa, Alessandra B.; Caltagirone, Carlo M.]
  • Differences in depression symptoms in patients with Alzheimer - [Weintraub D, Xie S, Karlawish J, Siderowf A]
  • Differences in depression symptoms in patients with Alzheimer - [Weintraub D, Xie S, Karlawish J, Siderowf A]
  • Depression and chronic medical illnesses in Asian older adults-the role of subjective health and functional status - [Niti M, Ng TP, Kua EH, Ho RC, Tan CH.]
  • Using the Internet to enhance the treatment of depression - [Robertson L, Smith M, Castle D, Tannenbaum D]
  • Early improvement under mirtazapine and paroxetine predicts later stable response with high sensitivity in patients with major depression - [A. Szegedi, M. J. Müller and O. Benkert 404.]
  • Early Improvement Under Mirtazapine and Paroxetine Predicts Later Stable Response and Remission With High Sensitivity in Patients WITH Major Depression - [Szegedi A, Müller MJ, Anghelescu I, Klawe C, Kohnen R, Benkert O.]
  • Impairment of several immune functions in anxious women - [Arranz L, Guayerbas N, De la Fuente M.]
  • Use of mental health services in Europe results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project - [Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lépine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonel]
  • 12-Month comorbidity patterns and associated factors in Europe-results from European Study of the Epidemiology of Mental Disorders (ESEMeD) project - [Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lépine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonel]
  • Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder - [Jaeger J, Berns S, Loftus S, Gonzalez C, Czobor P.]
  • Quality of life in patients with Behc ets disease-the impact of major depression - [U?uz F, Dursun R, Kaya N, Cilli AS.]
  • Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients - [Alan F Schatberg, Charlotte Kremer, Heidi E Rodrigues, Geer M Murphy Jr.]
  • Double-Blind,Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients - [Schatzberg AF, Kremer C, Rodrigues HE, Murphy GM; Mirtazapine vs. Paroxetine Study Group.]
  • Comorbid anxiety disorders in depressed elderly patients - [Lenze EJ, Mulsant BH, Shear MK, Schulberg HC, Dew MA, Begley AE, Pollock BG, Reynolds CF.]
  • Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjects - [David J. Brunswick, David B. P. Goodman, John P. O]
  • Immune–endocrine host response to endotoxin in major depression - [Vedder H, Schreiber W, Schuld A, Kainz M, Lauer CJ, Krieg JC, Holsboer F, Pollm?cher T.]
  • Economic costs of minor depression a population-based study - [Cuijpers P, Smit F, Oostenbrink J, de Graaf R, Ten Have M, Beekman A.]
  • Platelet counts in depressed patients treated with amitriptyline or paroxetine - [F. Lederbogen, E. H?rer, R. Hellweg, I. Heuser and M. Deuschle]
  • A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance - [F. Ridout *, R. Meadows, S. Johnsen, I. Hindmarch AD:HPRU Medical Research Centre, University of Surrey, Egerton Road, Guildford GU2 7XP, UK]
  • Paroxetine in the treatment of depressed patients with haematological malignancy: an open-label study - [Chi-Un Pae 1, Yoo-Jin Kim 2, Wang-Youn Won 1, Hee-Je Kim 2, Seok Lee 2, Chang-Uk Lee 1, Soo-Jung Lee 1, Dong-Wook Kim 2, Chul Lee 1 *, Woo-Sung Min 2, Chun-Choo Kim 2, In-Ho Paik 1, Alessandro Serretti 3 AD:1Department of Psychiatry, Kangnam St Mary]
  • Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects - [Norio Yasui-Furukori, Manabu Saito, Yoshimasa Inoue, Takenori Niioka, Yasushi Sato, Shoko Tsuchimine, Sunao Kaneko]
  • Effect of antenatal exposure to paroxetine (Paxil) on growth and physical maturation of mice offspring - [William F. Rayburn 1 2 *, Christina L. Gonzalez 1 2, H. Dix Christensen 1 2, Thomas C. Kupiec 3, Jesse A. Jacobsen 2, Jeffrey D. Stewart 1 AD:1Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma2]
  • A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies - [Fiona J. Mackay, Nicholas R. Dunn, Lynda V. Wilton, Gillian L. Pearce, Shayne N. Freemantle, Ronald D. Mann * AD:Drug Safety Research Unit, Bursledon Hall, Southampton, UK]
  • Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression? - [Denis Joseph Paul David, Bríd á. Nic Dhonnchadha, Pascale Jolliet, Martine Hasco?t and Michel Bourin]
  • Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. - [Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L]
  • Binding of S-citalopram and paroxetine discriminates between species - [Betina Elfving *, Ove Wiborg AD:Laboratory of Molecular Neurobiology, Department of Biological Psychiatry, Aarhus Psychiatric University Hospital, Risskov, Denmark]
  • Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients - [Jen-Ping Hwang, Cheng-Hung Yang, Shih-Jen Tsai * AD:Department of Psychiatry, Taipei Veterans General Hospital, and Division of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China]
  • Effectiveness of Fluvoxamine and Paroxetine in Major Depressives with Psychotic Features - [EMILIO SACCHETTI 1 *, GIOVANNI CONTE 2, LAURA GUARNERI 3, ALESANDRO CALZERONI 2, MARA BERTINI 4, ADELAIDE PANARIELLO 4 AD:1Institute of Psychiatry, Second Chair Brescia University School of Medicine, Brescia, Italy2ASSL 39, University Department of Mental]
  • Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine - [P. Vandel 1, D. Sechter 1, E. Weiller 2, N. Pezous 2, F. Cabanac 2, A. Tournoux 2, E. Panconi 2 AD:1Service de Psychiatrie et Psychologie Médicale, CHU St Jacques, Besan?on, France2Institut De Recherche Pierre Fabre, Boulogne, France]
  • Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular dopamine in the frontal cortex of freely moving rats - [Jenny C.E. Owen and Peter S. Whitton]
  • Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity - [Gregers Wegener, Vallo Volke, Brian H. Harvey and Raben Rosenberg]
  • Fetal and adolescent nicotine administration: effects on CNS serotonergic systems - [Z. Xu, F. J. Seidler, S. F. Ali, W. Slikker and T. A. Slotkin]
  • Permanent, Sex-Selective Effects of Prenatal or Adolescent Nicotine Exposure, Separately or Sequentially, in Rat Brain Regions: Indices of Cholinergic and Serotonergic Synaptic - [Function, Cell Signaling, and Neural Cell Number and Size at 6 Months of AgeTheodore A Slotkin1, Emiko A MacKillop1, Charles L Rudder1, Ian T Ryde1, Charlotte A Tate1 and Frederic J Seidler1]
  • Neuropsychiatric Complications After Liver Transplantation Role of Immunosuppression and Hepatitis C - [Tombazzi CR, Waters B, Shokouh-Amiri MH, Vera SR, Riely CA.]
  • by NMDA receptor blockade-Memantine and beyond - [Lipton SA.]
  • Identification of single-nucleotide polymorphisms of the human neurokinin 1 receptor gene and pharmacological characterization of a Y192H variant - [G P Randolph1, J S Simon1, M G Arreaza1, P Qiu1, J E Lachowicz1 and R A Duffy1]
  • The Gerbil Elevated Plus-maze II: Anxiolytic-like Effects of Selective Neurokinin NK1 Receptor Antagonists - [Geoffrey B Varty Ph.D, Mary E Cohen-Williams BSc, Cynthia A Morgan BSc, Ursula Pylak MS, Ruth A Duffy Ph.D, Jean E Lachowicz Ph.D, Galen J Carey Ph.D and Vicki L Coffin Ph.D]
  • Neurocognitive Deterioration in Elderly Chronic Schizophrenia Patients With and Without PTSD - [Goodman C, Finkel B, Naser M, Andreyev P, Segev Y, Kurs R, Melamed Y, Bleich A.]
  • Serotonin transporter and MAO-B levels in monoamine nuclei of the human brainstem are normal in major depression - [Violetta Klimek, Gary Roberson, Craig A. Stockmeier and Gregory A. Ordway]
  • Pharmacogenetics of antidepressant medication intolerance - [Greer M Murphy Jr, Charlotte Kremer, Heidi E Rodrigues, Alan F Schatzberg]
  • Multidrug-Resistant Tuberculosis=A MenaceThat Threatens To Destabilize Tuberculosis Control - [Sharma SK, Mohan A.]
  • Electric Sensations: Neglected Symptom of Escitalopram Discontinuation - [Nadia Feth, Katja Cattapan-Ludewig, Eveline Jaquenoud Sirot]
  • Serotonergic activity measured by platelet [3H]paroxetine binding in patients with eating disorders - [Carla E. Ramacciotti, Elisabetta Coli, Riccardo Paoli, Donatella Marazziti and Liliana Dell'Osso]
  • Time course of dopamine D2 receptor occupancy by clozapine with medium and high plasma concentrations - [Akihiro Takano, Tetsuya Suhara, Ichiro Kusumi, Yoshito Takahashi, Yoshiyuki Asai, Fumihiko Yasuno, Tetsuya Ichimiya, Makoto Inoue, Yasuhiko Sudo and Tsukasa Koyama]
  • Neurotransmitter transporters: fruitful targets for CNS drug discovery - [L Iversen]
  • Association Study of a Monoamine Oxidase A Gene Promoter Polymorphism with Major Depressive Disorder and Antidepressant Response - [Younger W-Y Yu1, Shih-Jen Tsai2,3, Chen-Jee Hong2,3, Tai-Jui Chen4,5, Ming-Chao Chen6 and Chih-Wei Yang5]
  • Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative - [Feng C. Zhou, Klaus-Peter Lesch and Dennis L. Murphy]
  • Modafinil does not affect serotonin efflux from rat frontal cortex synaptosomes: comparison with known serotonergic drugs - [Luca Ferraro, Sergio Tanganelli, Kjell Fuxe, Bertha Wonje Bebe, Maria Cristina Tomasini, Francis A. Rambert and Tiziana Antonelli]
  • Mirtazapine versus fluoxetine in the treatment of panic disorder - [L. Ribeiro, J.V. Busnello,M. Kauer-Sant’Anna,M. Madruga, J. Quevedo,E.A.D. Busnelloand F. Kapczinski]
  • Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [11C]DASB Positron Emission Tomography Study - [Jeffrey H Meyer, Alan A Wilson, Sandra Sagrati, Doug Hussey, et al]
  • Recent advances in understanding migraine mechanisms, molecules and therapeutics - [Goadsby PJ.]
  • Aging regulates 5-HT1B receptors and serotonin reuptake sites in the SCN - [Marilyn J. Duncan, Charles J. Crafton and Deborah L. Wheeler]
  • Early Methylphenidate Administration to Young Rats Causes a Persistent Reduction in the Density of Striatal Dopamine Transporters - [Gunther H. Moll, Sharmila Hause, Eckart Rüther, Aribert Rothenberger, Gerald Huether]
  • Treatment of vasomotor symptoms: Is there an alternative to hormone replacement therapy? - [Nadia F. Soliman]
  • Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist - [Beth Borowsky, Margaret M. Durkin, Kristine Ogozalek, Mohammad R. Marzabadi, John DeLeon, Rainer Heurich, Harvey Lichtblau, Zoya Shaposhnik, Irena Daniewska, Thomas P. Blackburn, Theresa A. Branchek, Christophe Gerald, Pierre J. Vaysse, Carlos Forray]
  • Treatment with medications affecting dopaminergic and serotonergic mechanisms: Effects on fluency and anxiety in persons who stutter - [Sheila V. Stager, Karim Calis, Dale Grothe, Meir Bloch, Nannette M. Berensen, Paul J. Smith and Allen Braun]
  • Heart rate variability in premenstrual dysphoric disorder - [Mikael Landén, Bertil Wennerblom, Hans Tygesen, Kjell Modigh, Karin S?rvik, Christina Ysander, Agneta Ekman, Hans Nissbrandt, Marie Olsson and Elias Eriksson]
  • Fluoxetine Alone in the Treatment of First Episode anxious-depression-an open clinical trial - [Spalletta G, Pasini A, Caltagirone C.]
  • Fluoxetine Alone in the Treatment of First Episode Anxious-Depression： An Open Clinical Trial - [Spalletta G, Pasini A, Caltagirone C.]
  • Clozapine-induced angioneurotic edem - [Mishra B, Sahoo S, Sarkar S, Akhtar S.]
  • Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: a potential role for sodium channels? - [Mirza NR, Bright JL, Stanhope KJ, Wyatt A, Harrington NR]
  • Testosterone replacement therapy for male hypogonadism - [Seftel A.]
  • Resistin and adiponectin in major depression: The association with free cortisol and effects of antidepressant treatment - [Bettina Weber-Hamann, Jürgen Kratzsch, Daniel Kopf, Florian Lederbogen, Maria Gilles, Isabella Heuser and Michael Deuschle]
  • Pharmacotherapy for major depression in children and adolescents - [Karen Dineen Wagner]
  • MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders - [E Geuze1,2, E Vermetten1,2 and J D Bremner3,4,5]
  • P01.15 Neurocognitive changes in adjustment disorder with depressed mood: Use of paroxetine - [.]
  • Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients - [Solisbella Pe?a, Edith Baccichet, Mary Urbina, Isabel Carreira and Lucimey Lima]
  • Impact of low back pain on functional limitations,depressed mood and quality of life in patients with rheumatoid arthritis - [Kothe R, Kohlmann T, Klink T, Rüther W, Klinger R.]
  • Olanzapine, quetiapine, and risperidone: long-term effects on monoamine transporters in rat forebrain - [Frank I. Tarazi, Kehong Zhang and Ross J. Baldessarini]
  • Lithium Augmentation Increases the ACTH and Cortisol Response in the Combined DEX/CRH Test in Unipolar Major Depression - [Tom Bschor1 MD, Mazda Adli2 MD, Christopher Baethge2 MD, Uta Eichmann2, Marcus Ising3 Ph.D, Manfred Uhr3 MD, Sieglinde Modell3 MD, Heike Künzel3 MD, Bruno Müller-Oerlinghausen2 MD and Michael Bauer4 Ph.D, MD]
  • Gene expression and association analysis of LIM (PDLIM5) in major depression - [Jun-ichi Iga, Shu-ichi Ueno, Ken Yamauchi, Shusuke Numata, Ikuyo Motoki, Sumiko Tayoshi, Sawako Kinouchi, Koshi Ohta, Hongwei Song, Kyoko Morita, et al.]
  • Reactions liees a l'arret du traitement aux ISRS - [Macdonald, Lynn]
  • Effects of Antidepressants on Weight and on the Plasma Levels of Leptin, TNF-[alpha] and Soluble TNF Receptors: A Longitudinal Study in Patients Treated with Amitriptyline or Paroxetine - [Dunja Hinze-Selch, Andreas Schuld, Thomas Kraus, Martin Kühn, Manfred Uhr, Monika Haack, Thomas Pollm?cher]
  • Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review - [K M Smits1, L J M Smits1, J S AG Schouten1, F F Stelma1, P Nelemans1 and M H Prins1]
  • Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test - [Fernando T. Consoni, Maria A.B.F. Vital and Roberto Andreatini]
  • Aging alters in a region-specific manner serotonin transporter sites and 5-HT1A receptor-G protein interactions in hamster brain - [Marilyn J. Duncan and Julie G. Hensler]
  • NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2receptors-implications for models of schizophrenia - [S Kapur1 and P Seeman1,2]
  • METHYLPHENIDATE IN STROKE PATIENTS WITH DEPRESSION - [Johnson, Maria Lee; Roberts, Michael D.; Ross, Angelita R.; Witten, Celia M.]
  • Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine - [Ernst A. Lien, Per M. Ueland, Per E. L?nning]
  • Facing the evidence: antidepressant treatment in children and adolescents - [E Jane Garland]
  • The Formation of Abnormal Associations in Schizophrenia Neural and Behavioral Evidence - [Jensen J, Willeit M, Zipursky RB, Savina I, Smith AJ, Menon M, Crawley AP, Kapur S.]
  • The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain - [V Sanchez, J Camarero, B Esteban, M J Peter, A R Green, M I Colado]
  • Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke monoamine release - [I C Kilpatrick, M Traut, D J Heal]
  • Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus - [Rebeca Martinez-Turrillas, Diana Frechilla and Joaquín Del Río]
  • Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome? - [Masand PS, Gupta S, Schwartz TL, Kaplan D, Virk S, Hameed A, Lockwood K]
  • Impaired release of β-endorphin in response to serotonin in a rat model of depression - [A. Zangen, R. Nakash, I. Roth-Deri, D. H. Overstreet and G. Yadid]
  • Emergence, persistence, and resolution of suicidal ideation during treatment of depression in old age - [Katalin Szanto, Benoit H. Mulsant, Patricia R. Houck, Mary Amanda Dew, Alexandre Dombrovski, Bruce G. Pollock and Charles F. Reynolds III]
  • Serotonin and Premature Ejaculation: From Physiology to Patient Management - [Fran?ois Giuliano and Pierre Clément]
  • Video game epilepsy in the twentieth century-a review - [Shoja MM, Tubbs RS, Malekian A, Jafari Rouhi AH, Barzgar M, Oakes WJ.]


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 [37] 38 39 40
    41 42 43 44 45 46 47 48 49 50